Herantis Pharma Oyj: Managers' Transactions – Tone Kvåle

Cision Publicerad: 14 Apr 2022 15:00

Herantis Pharma Plc

Company release 14 April 2022 at 4:00pm EEST

Herantis Pharma Oyj – Managers’ Transactions

____________________________________________

Person subject to the notification requirement

Name: Kvåle, Tone

Position: Chief Financial Officer

Issuer: Herantis Pharma Plc

LEI: 743700W4CQVYAT3WKK38

Notification type: INITIAL NOTIFICATION

Reference number: 13375/4/4

____________________________________________

Transaction date: 2022-04-14

Venue not applicable

Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT

Instrument name: 2021 option rights in Herantis Pharma Plc

Nature of the transaction: ACCEPTANCE OF A STOCK OPTION

Transaction details

(1): Volume: 50,000 Unit price: 0.00 EUR

Aggregated transactions

(1): Volume: 50,000 Volume weighted average price: 0.00 EUR

____________________________________________

Further information:

Julie Silber/Gabriela Urquilla

Tel: +46 (0)7 93 486 277/+46 (0)72-396 72 19

Certified Advisor: UB Securities Ltd, Finland: +358 9 25 380 225, Sweden: +358 40 5161400

Company website: www.herantis.com

Distribution:

Main media
www.herantis.com